TIIEX
Price
$16.46
Change
+$0.01 (+0.06%)
Updated
Jun 9 closing price
Net Assets
5.38B
VTISX
Price
$189.70
Change
+$0.56 (+0.30%)
Updated
Jun 9 closing price
Net Assets
652.3B
Interact to see
Advertisement

TIIEX vs VTISX

Header iconTIIEX vs VTISX Comparison
Open Charts TIIEX vs VTISXBanner chart's image
TIIEX vs VTISX Comparison Chart in %
View a ticker or compare two or three
VS
TIIEX vs. VTISX commentary
Jun 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TIIEX is a Hold and VTISX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTISX has more cash in the bank: 652B vs. TIIEX (5.38B). TIIEX (2.77) and VTISX (2.66) have matching dividends . TIIEX was incepted earlier than VTISX: TIIEX (27 years) vs VTISX (10 years). TIIEX (0.45) is less costly to investors than VTISX (0.05). TIIEX is a more actively managed with annual turnover of: 25.00 vs. VTISX (4.00). TIIEX has a lower initial minimum investment than VTISX: TIIEX (1000000) vs VTISX (3000000000). VTISX annual gain was more profitable for investors over the last year : 23.62 vs. TIIEX (10.27). VTISX return over 5 years is better than : 29.70 vs. TIIEX (25.26).
TIIEXVTISXTIIEX / VTISX
Total Expense Ratio0.450.05978%
Annual Report Gross Expense Ratio0.450.05978%
Fund Existence27 years10 years-
Gain YTD4.57710.80542%
Front LoadN/AN/A-
Min. Initial Investment100000030000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets5.38B652B1%
Annual Yield % from dividends2.772.66104%
Returns for 1 year10.2723.6243%
Returns for 3 years41.3053.0978%
Returns for 5 years25.2629.7085%
Returns for 10 years84.39102.8582%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AIR120.135.41
+4.72%
AAR Corp
LHX308.176.07
+2.01%
L3Harris Technologies
SBGI14.080.16
+1.15%
Sinclair
EQS1.32N/A
N/A
Equus Total Return
ALXO1.56-0.01
-0.64%
ALX Oncology Holdings